Testing effectiveness (Phase 2)Looking for participantsNCT06136403
What this trial is testing
A 44-week Monocentric Open Study Assessing the Efficacy and Safety of Deucravacitinib in Adults With Inflammatory Genodermatoses
Who this might be right for
Epidermolysis Bullosa SimplexIchthyosisGenodermatosis+1 more
Centre Hospitalier Universitaire de Nice 10